HIGHLIGHTS
- Who: A.Seval Ozgu-Erdinc and collaborators from the Guangzhou Medical University Cancer Hospital, China have published the paper: Research progress on m6A demethylase FTO and its role in gynecological tumors, in the Journal: (JOURNAL)
SUMMARY
A pivotal advancement in the field of epitranscriptomics was achieved with the characterization of FTO as the inaugural m6A demethylase, capable of facilitating dynamic and reversible epigenetic modifications. Initially, it was considered a widespread modification capable of selectively affecting gene_expression. It influences mRNA transcription, splicing, translation, localization and metabolism in the nucleus and further affects gene_expression, leading . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.